Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents

Medicinal Chemistry Research (Impact Factor: 1.4). 11/2007; 16(6):300-318. DOI: 10.1007/s00044-007-9033-8


Some new benzenesulfonamides, disubstituted sulfonylureas, and sulfonylthioureas substituted basically with 3-(2-thienyl or
3-pyridyl)-indeno[1,2-c]pyrazol(in)e counterpart were synthesized to be evaluated for their in vitro antitumor activity. Some
of the thioureido derivatives were cyclized to the corresponding five-membered thiazolidinons, thiazolines, and the six-membered
thiazinones as interesting structure variants. According to the protocol of the National Cancer Institute (NCI) in vitro disease-oriented
human cells screening panel assay, 13 compounds showed promising broad spectrum antitumor activity. In general, compounds
containing the thienyl moiety displayed better antitumor spectra than those containing the pyridyl moiety. Compound 5, 4-(3-(2-thienyl)-3H-indeno[1,2-c]pyrazol-2-yl)-benzenesulfonamide
[GI50, TGI, and LC50 (MG-MID) values of 13.2, 33.1 and 69.2μM, respectively] proved to be the most active member in this study with variable
degrees of potencies against all the tested subpanel tumor cell lines and particular effectiveness against the leukemia and
prostate subpanels at both the GI50 (3.30 and 8.68μM, respectively) and the TGI levels (15.7 and 22.3μM, respectively).

1 Follower
58 Reads
  • Source
    • "activity, viz. anti-inflammatory (Vazzanaa et al., 2004), antitubercular (Dandia et al., 2004), anticancer (Ali and Hassan, 2007), antitumor (Faidallah et al., 2007), anti- HIV (Ravichandran et al., 2008), antibacterial (Tsyalkovsky et al., 2005), antifungal (Ulusoy et al., 2002), anesthetic (Surrey, 1949), antiviral (Terzioglu et al., 2006), anticonvulsant (Gursoy and Terzioglu, 2005), diuretics (Raikwar et al., 2008), nematicidal (Srinivas et al., 2008), and antihistaminic activity (Diurno et al., 1992). We observed from the literature survey that the fluoroquinolones with hydrolyzable group, viz. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The title compounds 2-substituted phenyl-3-{1-cyclopropyl-6-fluoro-7-[4-(4-methoxyphenylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline} carboxamido-1,3-thiazolidin-4-ones 6a–j have been synthesized from lead molecule 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1; this reacted with thionyl chloride to give acid chloride 2 and with hydrazine hydrate to afford hydrazide 3. The hydrazide 3 on condensation with substituted aromatic aldehydes a–j gave Schiff base; these on reaction with N-(4-methoxyphenyl) piperazine and thioglycolic acid furnished title compounds 6a–j. All of the synthesized compounds have been established by elemental analysis. IR and NMR spectral data and have been screened for antifungal and antibacterial activities.
    Medicinal Chemistry Research 11/2009; 19(8). DOI:10.1007/s00044-009-9228-2 · 1.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The synthesis of some new 3-cyano-1,4,6-trisubstituted-2(1H)-pyridinones supported with various pharmacophores and functionalities at positin-1 is described. The in vitro anticancer activity of 24 of the newly synthesized compounds was evaluated according to the protocol of the NCI in vitro disease-oriented human cells screening panel assay. The results revealed that five compounds 4a–c, 7b, and 12b were able to display moderate antitumor potential against some of the tested subpanel tumor cell lines at the GI50 and TGI levels, however, with marginal or no cytotoxic (LC50) activity. The obtained data suggested that better antitumor activity was linked to derivatives with either 4-bromophenyl or 3,4-dimethoxyphenyl moieties, together with a 1-methyl-1H-pyrrol-2-yl counter part at positions 6 and 4, respectively. Consequently, the 3-cyano-4-(1-methyl-1H-pyrrol-2-yl)-6-(4-bromophenyl or 3,4-dimethoxyphenyl)-2(1H)-pyridinones 4a and 4b, could be considered as the most active members identified in this investigation as evidenced from their relative higher growth inhibitory (GI50 (MG-MID) 77.6 and 67.6μM, respectively) and cytostatic (TGI (MG-MID) 85.1 and 95.5μM, respectively) activities, when compared with the substituted thiocarbamoyl analog 7b and the bicyclic [1,2,4]triazolo[3,4-a]pyridine derivative 12b. KeywordsSynthesis–Chalcones–Pyridinones–Pyrrole–Thiophene–Anticancer activity
    Medicinal Chemistry Research 11/2010; 20(8):1260-1272. DOI:10.1007/s00044-010-9469-0 · 1.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dibenzo [c,h]-[1,6] naphthyridin-6-one (ARC-111) and its analogues can exhibit potent topoisomerase I targeting and antitumor activities. Quantitative structure-activity relationship (QSAR) studies on the antitumor activity of 22 ARC-111 analogues to RPMI 8402 (expressed as pIC50) were performed by using electronic, spatial, thermodynamic, and topological descriptors based on different chemometric tools including stepwise multiple linear regression (stepwise MLR), partial least squares (PLS), and artificial neural network (ANN). QSAR equations were examined using a training set of 18 compounds and an external test set of four compounds, which was divided by cluster analysis. The ANN model was the most powerful, with a square of predictive correlation coefficient R pred 2 of 0.963 for the test set; the R pred 2 values for stepwise MLR and PLS were 0.780 and 0.729, respectively. The results obtained with these models indicated that the antitumor activity of ARC-111 analogues depends strongly on electronic factors (such as sum of E-state of H-bond acceptors, dipole moment as debyes, and total energy). KeywordsAntitumor activity-Quantitative structure-activity relationship-Prediction-Partial least squares-Artificial neural network
    Medicinal Chemistry Research 12/2009; 19(9):1233-1244. DOI:10.1007/s00044-009-9266-9 · 1.40 Impact Factor
Show more

Similar Publications